Log In
Print
BCIQ
Print
Print this Print this
 

Migranal

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionDihydroergotamine (DHE) mesylate nasal spray
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMigraine
Indication DetailsTreat migraine
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today